Skip to main content
. 2009 May 27;100(9):1767–1771. doi: 10.1111/j.1349-7006.2009.01231.x

Figure 2.

Figure 2

Comparison of KAI1 immunoreactivity in distant metastases from breast cancer and in a cohort of unselected M0/Mx primary mammary carcinomas. The set of primary tumors has been described previously.( 14 ) Statistical analysis was carried out using the actual numbers of observed cases and the χ2‐test. (a) Frequency of KAI1‐positive cases in the whole metastasis set versus frequency of KAI1‐positive cases in the whole set of primary mammary carcinomas. (b) Frequency of KAI1‐positive cases in the ER‐positive subgroup of the metastasis set versus frequency of KAI1‐positive cases in the ER‐positive subgroup of the set of primary mammary carcinomas. (c) Frequency of KAI1‐positive cases in the ER‐negative subgroup of the metastasis set versus frequency of KAI1‐positive cases in the ER‐negative subgroup of the set of primary mammary carcinomas.